“All research and analysis data in the credible Headache Disorders Market report is mapped into an actionable model, with strategic recommendations from experts. Client needs are well understood by experts who utilize their expertise and strong knowledge base to identify and evaluate competition and develop strategic programs, with both short-term and long-term goals. This industry analysis report recognizes and analyzes emerging trends along with key drivers, challenges, and opportunities in the Headache Disorders Market industry. The winning Headache Disorders Market Report provides extensive statistical analysis of the market’s ongoing positive development, capacity, production, production value, costs/profits, supply/demand, and import/export
Businesses today prefer market research reports like Headache Disorders Market reports as they help in making better decisions, generating more revenue, prioritizing market goals and achieving profitable business. This market report contains chapters on the global market and related companies along with their profiles, which provide important data regarding their insights in terms of finances, product portfolios, investment plans, and market and business strategies. Exploitation of existing statistical tools and coherent models for market data analysis and forecasting makes the Headache Disorders Market research report perform better.
The expected CAGR of headache disorders market is tend to be around 6.4% in the mentioned forecast period. The market was valued at USD 3.99 billion in 2022, and it would grow up to USD 6.55 billion by 2030.
Explore Further Details about This Research Headache Disorders Market Report https://www.databridgemarketresearch.com/reports/global-headache-disorders-market
Headache Disorders Market Scope and Segmentation
|
REPORT METRIC |
DETAILS |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 – 2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Migraine, Tension-type Headache, Cluster Headache, Medication-overuse Headache, Others), Diagnosis (Complete Blood Count, Skull X-rays, Sinus X-rays, CT Scan, Magnetic Resonance Imaging (MRI), Others), Treatment (Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Hikma Pharmaceuticals PLC (U.K.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH. (Germany), Dr. Reddy’s Laboratories Ltd. (India), Gilead Sciences, Inc. (U.S.), Amgen Inc. (U.S.), AbbVie Inc. (U.S.), Lilly (U.S.) |
|
Market Opportunities |
|
Market Definition
Headache disorders is the most widespread nervous system disorders which are typically characterized by consistent headaches. Headache is an extreme and disabling symptom of a few major headache disorders, which includes migraine, cluster headache, tension-type headache and others. Another incident cause of headache is overuse of medication. Antipsychotic medications, antiseizure medications, calcium channel blockers, antidepressants, and nonsteroidal anti-inflammatory drugs (NSAIDs) are the numerous drugs used in the treatment of headache disorders.
Global Headache Disorders Market Dynamics
Drivers
- Rising Cases of Depression
The increasing number of cases of depression is a primary factor boosting the headache disorders market’s growth rate during the forecast period of 2023-2030. Unhealthy lifestyle of people such as high alcohol consumption, severe changes in eating or sleeping pattern are the major risk factors which is expanding the frequency of depression and further causing headache. Additionally, emotional stress associated with family and friends, school or work is anticipated to boost the market’s growth rate during the forecast period.
- Increased Healthcare Expenditure
A major factor prompting the growth rate of headache disorders market is the increasing healthcare expenditure that helps in improving its improved infrastructure. Moreover, numerous government organizations aims to improve the healthcare infrastructure by growing funding and this will in turn influence the market dynamics. Thus, it boost the market growth.
Opportunities
- Increasing Demand of Preventive Treatment
Preventive or prophylactic treatment which includes prescription of off-label and generic medications named beta-blockers such as atenolol and propranolol, anti-epileptics such as topiramate, and divalproex sodium. Presently, Allergan’s Botox, Amgen/ Novartis’s Aimovig, and Teva’s Ajovy (CGRP mAb) are the only drugs that are approved for migraine prevention. Though, Botox requires more than 30 injections across the forehead, shoulders, and neck and does not provide relief from episodic migraine.
Key Insights Of Headache Disorders Market Report
- The report comprises a detailed analysis of different segments and offers market valuations between 2023 to 2030.
- This study presents the analytical depiction of the Headache Disorders Market with the current trends and future estimations to determine the imminent investment pockets
- The report also reveals information with respect to key drivers, restraints, and opportunities coupled with a comprehensive analysis of the global Headache Disorders Market
- The forecast period of the Headache Disorders Market is assessed from 2024 to 2030 to highlight the Headache Disorders Market growth scenario.
- Porter’s five forces analysis establishes the effectiveness of the buyers and suppliers in the business line.
- The key players in the industry are profiled to gain an understanding of the strategies adopted by them.
- This report provides the current trends and future estimations during the forecast period, which in turn aids in identify the prevailing market opportunities.
The company portfolio includes company synopsis, operating business sectors, business overview, product/service categories, and recent growth strategies adopted by them.
Browse Related Reports:
Onion Powder Market Size, Share & Trends [Report]
Asia-Pacific E-Commerce Packaging Market Share Statistics Report,Size, Forecast, & Trends
Russia Refractories Market Size, Global Industry Share, Recent
Intravenous Iron Market by Size, Share, Forecasts, & Trends
Food Allergy Market Size | Statistics Report, Share, Forecast, & Trends
Sales Tax Software Market Size, Share & Trends Analysis Report
Bioreactors Market Size and Forecasts, Share and Trends
Countertops Market Size, Industry Share, Forecast
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
“
